Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06370871
Status:
WITHDRAWN
Last Update Posted:
2024-05-14
First Post:
2024-04-15
Brief Title:
Brightline-3 A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma
Sponsor:
Organization:
Boehringer Ingelheim